What can we help you find?

Search for:

Our business development & licensing news

Search:

Filter year:

Category:

All

Cardiometabolic diseases

Enabling/platform technologies

Immunology

Infectious diseases and vaccines

Oncology

Neuroscience

Ophthalmology

Show more

Items per page

1-10 of 100

Connect with us on social

For patients and health care professionals

MerckHelps
Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients.
Merck Access Program
Information about insurance coverage and financial assistance options for eligible patients.
Clinical trials
Learn about our clinical trials and find available studies.
Merck Manuals
Medical information source covering thousands of topics in all fields of medicine.

Sustainability

Impact Report
Reporting on our commitment to operating responsibly to benefit society.
Merck for Mothers
An initiative to create a world where no woman has to die giving life.

About Merck

Merck Animal Health
The global animal health business unit of Merck.
Health Plan - Transparency in Coverage
In compliance with the Consolidated Appropriations Act, learn more about our health plan’s pricing information.
Contact Us
If you have a question or need more information about us, find out who you should contact.

Forward-looking statement
Cookie policy
Privacy
Transparency disclosure
Terms of use
Accessibility
Sitemap
Consumer Health Data Privacy Policy
Your Privacy Choices

Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA

This website of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2025 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept